Enroll-HD
Clinical Research
A collaboration between Huntington’s disease families, clinicians, and researchers to accelerate progress toward effective treatments.
Current Participants
Your information is powerful! Learn about current research opportunities.
Enroll-HD
Clinical research platform
Enroll-HD is a clinical research platform and the world’s largest observational study for Huntington’s disease families. It is a resource for the entire HD community, including families, clinicians, researchers, advocates, and anyone else who has a connection to or an interest in HD.
A platform for the whole HD community.
Current Participants
Clinical Sites Worldwide
Nations Participating
Enroll-HD: July 01, 2026 data cut
Contact us for trial support
Send us a message. An Enroll-HD team member will get back to you as soon as possible.
Enroll-HD
News
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
From huntingtin-lowering medicines to gene...
Skyhawk’s drug trial takes flight in the US
Skyhawk's FALCON-HD trial has dosed...
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
The FDA has accepted uniQure's...
October 2026: This Month in Huntington’s Disease Research
From sticky thoughts and pigs...
EHDN Clinical Research Congress 2026
Krakow, Poland | October 22–24, 2026
EN 
ES 
IT 
DE 
FR 